Annual SG&A
$5.90 M
-$594.10 K-9.15%
31 December 2023
Summary:
ZIVO Bioscience annual selling, general & administrative expenses is currently $5.90 million, with the most recent change of -$594.10 thousand (-9.15%) on 31 December 2023. During the last 3 years, it has risen by +$1.08 million (+22.34%). ZIVO annual SG&A is now -11.91% below its all-time high of $6.69 million, reached on 31 December 2021.ZIVO Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.94 M
-$4.03 M-67.49%
30 September 2024
Summary:
ZIVO Bioscience quarterly selling, general & administrative expenses is currently $1.94 million, with the most recent change of -$4.03 million (-67.49%) on 30 September 2024. Over the past year, it has increased by +$587.20 thousand (+43.31%). ZIVO quarterly SG&A is now -67.49% below its all-time high of $5.98 million, reached on 30 June 2024.ZIVO Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$516.90 M
-$13.69 M-2.72%
30 September 2024
Summary:
ZIVO Bioscience TTM selling, general & administrative expenses is currently -$516.90 million, with the most recent change of -$13.69 million (-2.72%) on 30 September 2024. Over the past year, it has dropped by -$523.33 million (-8141.69%). ZIVO TTM SG&A is now -1245451.08% below its all-time high of $10.48 million, reached on 30 September 2024.ZIVO TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ZIVO Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -9.2% | +43.3% | -8141.7% |
| 3 y3 years | +22.3% | +53.7% | -9871.0% |
| 5 y5 years | +77.9% | +85.3% | -10000.0% |
ZIVO Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -11.9% | +22.3% | -67.5% | +99.2% | -26.5% | at low |
| 5 y | 5 years | -11.9% | +77.9% | -67.5% | +227.6% | -56.7% | at low |
| alltime | all time | -11.9% | >+9999.0% | -67.5% | >+9999.0% | <-9999.0% | at low |
ZIVO Bioscience Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.94 M(-67.5%) | $10.48 M(+5.9%) |
| June 2024 | - | $5.98 M(+512.7%) | $9.90 M(+86.6%) |
| Mar 2024 | - | $975.60 K(-38.6%) | $5.30 M(-10.1%) |
| Dec 2023 | $5.90 M(-9.2%) | $1.59 M(+17.1%) | $5.90 M(-8.2%) |
| Sept 2023 | - | $1.36 M(-2.1%) | $6.43 M(-0.6%) |
| June 2023 | - | $1.39 M(-11.7%) | $6.47 M(-3.6%) |
| Mar 2023 | - | $1.57 M(-26.0%) | $6.71 M(+3.4%) |
| Dec 2022 | $6.49 M(-3.0%) | $2.12 M(+51.6%) | $6.49 M(-8.5%) |
| Sept 2022 | - | $1.40 M(-14.3%) | $7.10 M(+1.9%) |
| June 2022 | - | $1.63 M(+21.0%) | $6.96 M(+5.3%) |
| Mar 2022 | - | $1.35 M(-50.6%) | $6.62 M(-1.3%) |
| Dec 2021 | $6.69 M(+38.9%) | $2.72 M(+115.5%) | $6.71 M(+26.8%) |
| Sept 2021 | - | $1.26 M(-1.4%) | $5.29 M(-13.2%) |
| June 2021 | - | $1.28 M(-10.8%) | $6.10 M(+12.7%) |
| Mar 2021 | - | $1.44 M(+9.9%) | $5.41 M(+12.2%) |
| Dec 2020 | $4.82 M(-20.3%) | $1.31 M(-36.8%) | $4.82 M(-29.3%) |
| Sept 2020 | - | $2.07 M(+248.9%) | $6.82 M(+17.6%) |
| June 2020 | - | $593.20 K(-30.2%) | $5.80 M(-7.9%) |
| Mar 2020 | - | $850.00 K(-74.3%) | $6.29 M(+4.1%) |
| Dec 2019 | $6.05 M(+82.3%) | $3.31 M(+215.3%) | $6.05 M(+59.2%) |
| Sept 2019 | - | $1.05 M(-3.8%) | $3.80 M(+2.9%) |
| June 2019 | - | $1.09 M(+81.0%) | $3.69 M(+16.7%) |
| Mar 2019 | - | $601.80 K(-43.2%) | $3.16 M(-4.7%) |
| Dec 2018 | $3.32 M(-16.0%) | $1.06 M(+12.7%) | $3.32 M(-13.4%) |
| Sept 2018 | - | $939.70 K(+67.4%) | $3.83 M(-13.0%) |
| June 2018 | - | $561.20 K(-25.8%) | $4.40 M(+4.2%) |
| Mar 2018 | - | $756.10 K(-51.9%) | $4.22 M(+6.9%) |
| Dec 2017 | $3.95 M(+46.2%) | $1.57 M(+4.0%) | $3.95 M(+39.4%) |
| Sept 2017 | - | $1.51 M(+291.3%) | $2.83 M(+51.1%) |
| June 2017 | - | $385.90 K(-20.0%) | $1.87 M(-34.4%) |
| Mar 2017 | - | $482.30 K(+6.1%) | $2.86 M(+5.7%) |
| Dec 2016 | $2.70 M(+33.5%) | $454.70 K(-17.5%) | $2.70 M(+1.8%) |
| Sept 2016 | - | $551.40 K(-59.7%) | $2.65 M(-0.6%) |
| June 2016 | - | $1.37 M(+316.9%) | $2.67 M(+33.6%) |
| Mar 2016 | - | $328.00 K(-19.2%) | $2.00 M(-1.3%) |
| Dec 2015 | $2.02 M(+13.0%) | $405.90 K(-28.6%) | $2.02 M(-0.7%) |
| Sept 2015 | - | $568.40 K(-18.3%) | $2.04 M(-0.9%) |
| June 2015 | - | $695.30 K(+96.7%) | $2.06 M(+17.1%) |
| Mar 2015 | - | $353.40 K(-15.9%) | $1.76 M(-1.9%) |
| Dec 2014 | $1.79 M(-14.4%) | $420.40 K(-28.5%) | $1.79 M(-4.1%) |
| Sept 2014 | - | $587.60 K(+48.8%) | $1.87 M(-1.6%) |
| June 2014 | - | $394.90 K(+1.9%) | $1.90 M(-8.5%) |
| Mar 2014 | - | $387.70 K(-22.1%) | $2.07 M(-0.9%) |
| Dec 2013 | $2.09 M | $497.50 K(-19.4%) | $2.09 M(+10.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2013 | - | $617.30 K(+8.0%) | $1.90 M(+11.9%) |
| June 2013 | - | $571.50 K(+40.8%) | $1.70 M(+19.1%) |
| Mar 2013 | - | $405.90 K(+33.2%) | $1.42 M(+0.0%) |
| Dec 2012 | $1.40 M(-8.1%) | $304.80 K(-26.5%) | $1.42 M(-25.6%) |
| Sept 2012 | - | $414.80 K(+38.5%) | $1.91 M(+10.8%) |
| June 2012 | - | $299.40 K(-26.1%) | $1.73 M(+7.1%) |
| Mar 2012 | - | $405.20 K(-49.0%) | $1.61 M(+5.7%) |
| Dec 2011 | $1.53 M(-58.7%) | $794.90 K(+248.2%) | $1.53 M(+11.3%) |
| Sept 2011 | - | $228.30 K(+23.3%) | $1.37 M(-14.6%) |
| June 2011 | - | $185.10 K(-41.8%) | $1.61 M(-48.9%) |
| Mar 2011 | - | $317.80 K(-50.4%) | $3.14 M(-14.9%) |
| Dec 2010 | $3.70 M(+58.7%) | $640.10 K(+38.5%) | $3.70 M(-1.3%) |
| Sept 2010 | - | $462.10 K(-73.2%) | $3.74 M(-10.9%) |
| June 2010 | - | $1.72 M(+98.0%) | $4.20 M(+51.6%) |
| Mar 2010 | - | $870.40 K(+26.7%) | $2.77 M(+19.0%) |
| Dec 2009 | $2.33 M(+110.2%) | $686.90 K(-25.5%) | $2.33 M(+27.4%) |
| Sept 2009 | - | $921.70 K(+214.6%) | $1.83 M(+62.1%) |
| June 2009 | - | $293.00 K(-31.5%) | $1.13 M(-11.1%) |
| Mar 2009 | - | $427.70 K(+130.6%) | $1.27 M(+14.5%) |
| Dec 2008 | $1.11 M(-41.8%) | $185.50 K(-16.3%) | $1.11 M(-12.2%) |
| Sept 2008 | - | $221.50 K(-49.0%) | $1.26 M(-24.6%) |
| June 2008 | - | $434.10 K(+62.6%) | $1.68 M(+5.0%) |
| Mar 2008 | - | $267.00 K(-21.5%) | $1.60 M(-16.2%) |
| Dec 2007 | $1.90 M(-46.4%) | $340.00 K(-46.4%) | $1.91 M(-15.1%) |
| Sept 2007 | - | $634.30 K(+79.1%) | $2.24 M(-7.7%) |
| June 2007 | - | $354.20 K(-38.6%) | $2.43 M(-23.2%) |
| Mar 2007 | - | $576.50 K(-15.2%) | $3.17 M(-10.8%) |
| Dec 2006 | $3.55 M(+19.7%) | $679.70 K(-17.4%) | $3.55 M(-3.6%) |
| Sept 2006 | - | $822.70 K(-24.4%) | $3.69 M(-16.8%) |
| June 2006 | - | $1.09 M(+13.4%) | $4.43 M(+21.4%) |
| Mar 2006 | - | $959.80 K(+17.9%) | $3.65 M(+21.7%) |
| Dec 2005 | $2.97 M(-18.2%) | $813.90 K(-48.0%) | $3.00 M(-12.9%) |
| Sept 2005 | - | $1.56 M(+408.8%) | $3.44 M(+44.5%) |
| June 2005 | - | $307.40 K(-0.9%) | $2.38 M(-1.6%) |
| Mar 2005 | - | $310.30 K(-75.3%) | $2.42 M(-33.3%) |
| Dec 2004 | $3.62 M(+647.4%) | $1.26 M(+148.5%) | $3.63 M(+27.2%) |
| Sept 2004 | - | $505.60 K(+45.7%) | $2.85 M(+21.5%) |
| June 2004 | - | $347.00 K(-77.1%) | $2.35 M(+17.3%) |
| Mar 2004 | - | $1.52 M(+214.9%) | $2.00 M(+312.5%) |
| Dec 2003 | $484.90 K(>+9900.0%) | $481.90 K(>+9900.0%) | $485.00 K(>+9900.0%) |
| Sept 2003 | - | $600.00(0.0%) | $3100.00(+24.0%) |
| June 2003 | - | $600.00(-68.4%) | $2500.00(+31.6%) |
| Mar 2003 | - | $1900.00 | $1900.00 |
| Dec 2002 | $3400.00 | - | - |
FAQ
- What is ZIVO Bioscience annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ZIVO Bioscience?
- What is ZIVO Bioscience annual SG&A year-on-year change?
- What is ZIVO Bioscience quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ZIVO Bioscience?
- What is ZIVO Bioscience quarterly SG&A year-on-year change?
- What is ZIVO Bioscience TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ZIVO Bioscience?
- What is ZIVO Bioscience TTM SG&A year-on-year change?
What is ZIVO Bioscience annual selling, general & administrative expenses?
The current annual SG&A of ZIVO is $5.90 M
What is the all time high annual SG&A for ZIVO Bioscience?
ZIVO Bioscience all-time high annual selling, general & administrative expenses is $6.69 M
What is ZIVO Bioscience annual SG&A year-on-year change?
Over the past year, ZIVO annual selling, general & administrative expenses has changed by -$594.10 K (-9.15%)
What is ZIVO Bioscience quarterly selling, general & administrative expenses?
The current quarterly SG&A of ZIVO is $1.94 M
What is the all time high quarterly SG&A for ZIVO Bioscience?
ZIVO Bioscience all-time high quarterly selling, general & administrative expenses is $5.98 M
What is ZIVO Bioscience quarterly SG&A year-on-year change?
Over the past year, ZIVO quarterly selling, general & administrative expenses has changed by +$587.20 K (+43.31%)
What is ZIVO Bioscience TTM selling, general & administrative expenses?
The current TTM SG&A of ZIVO is -$516.90 M
What is the all time high TTM SG&A for ZIVO Bioscience?
ZIVO Bioscience all-time high TTM selling, general & administrative expenses is $10.48 M
What is ZIVO Bioscience TTM SG&A year-on-year change?
Over the past year, ZIVO TTM selling, general & administrative expenses has changed by -$523.33 M (-8141.69%)